Cardiovascular disease still kills 200 women a day in France, with younger and younger women affected (Santé Publique France). The cause is lifestyle, which accounts for 80% of these accidents. Women are also 40% more likely than men to be under-diagnosed and under-treated.

The ambition of the “Agir pour le Cœur des Femmes” Endowment Fund is to save the lives of 10,000 women within 5 years, in particular through its national prevention campaign “Le Bus du Cœur des Femmes”.

Between September 2021 and November 2023, a total of 8030 pre-registered women were screened in 34 towns. The study of precariousness was carried out starting in 2022, using the CNAM's Epices Score. Anonymized “paper” files were used to process more one million data by a specialist company, Handisanté, before statistical analysis at the Lille University Hospital Research Department.

The ONSF provides an overview of women's overall health in France. The descriptive analysis includes women aged between 14 and 96 (average age 55). Among them, 66% were post-menopausal and 52.1% were in precarious situations (EPICES score>4), with wide variations from center to center. Three clusters of women sharing common characteristics were identified sharing the same insecurities and the same severity of precarity. Nine out of 10 women had at least 2 CV risk factors (FRCV), 46% had at least 2 gyneco-obstetrical risk factors (FRGO); 26.5% were known to have hypertension, 81.7% of whom were treated; 67% said they were stressed; 30.5% were obese (BMI>30) and 26.7% were sedentary. Despite being at CV risk, 79% had no cardiological follow-up. Over the three years, post-menopausal women had better follow-up by their general practitioner and cardiologist than non-menopausal women, but there was a drop in gynaecological follow-up from the age of 69 onwards. Over 90% of the women screened were satisfied.

The ONSF highlights the urgency of the health situation for women in France, some of whom have drifted away from regular care channels. It underscores the need for proactive care and for screening to be extended to a greater number of towns and cities, based on alternative, more agile initiatives, particularly in rural areas. From 2024, metabolic and echo-doppler screening data will be integrated for a more refined analysis of all FRCVs.